These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6789839)

  • 21. Identification of alloimmunized patients: use of radiolabeled allogeneic platelet kinetic measurements and platelet antibody tests.
    Bensinger WI; Hadlock J; Slichter SJ
    Blood; 1991 Jun; 77(11):2372-8. PubMed ID: 2039819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
    Heal JM; Blumberg N; Masel D
    Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A microplate ELISA for the detection of platelet alloantibodies: comparison with the platelet immunofluorescence test.
    Sintnicolaas K; van der Steuijt KJ; van Putten WL; Bolhuis RL
    Br J Haematol; 1987 Jul; 66(3):363-7. PubMed ID: 3304393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 25. An enzyme-linked immunosorbent assay for platelet compatibility testing.
    Tamerius JD; Curd JG; Tani P; McMillan R
    Blood; 1983 Oct; 62(4):744-9. PubMed ID: 6882922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four crossmatch methods to select platelet donors.
    Kakaiya RM; Gudino MD; Miller WV; Sherman LA; Katz AJ; Wakem CJ; Krugman DJ; Klatsky AU; Kiraly TR
    Transfusion; 1984; 24(1):35-41. PubMed ID: 6364475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of ABH antigens in platelet crossmatching.
    Heal JM; Mullin A; Blumberg N
    Transfusion; 1989; 29(6):514-20. PubMed ID: 2749874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-associated complement C3 in immune thrombocytopenic purpura.
    Myers TJ; Kim BK; Steiner M; Baldini MG
    Blood; 1982 May; 59(5):1023-8. PubMed ID: 7042000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABH antibodies causing platelet transfusion refractoriness.
    Brand A; Sintnicolaas K; Claas FH; Eernisse JG
    Transfusion; 1986; 26(5):463-6. PubMed ID: 3532447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
    Brand A; van Leeuwen A; Eernisse JG; van Rood JJ
    Blood; 1978 May; 51(5):781-8. PubMed ID: 346088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets.
    Schiffer CA; O'Connell B; Lee EJ
    Blood; 1989 Aug; 74(3):1172-6. PubMed ID: 2752158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
    Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
    Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matching of histocompatibility (HL-A) antigens for platelet transfusion.
    Mittal KK; Ruder EA; Green D
    Blood; 1976 Jan; 47(1):31-41. PubMed ID: 1244913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization.
    Friedberg RC; Donnelly SF; Boyd JC; Gray LS; Mintz PD
    Blood; 1993 Jun; 81(12):3428-34. PubMed ID: 8507878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloantibody-induced platelet serotonin release is blocked by antibody to the platelet PLA1 antigen.
    Duncan JR; Rosse WF
    Br J Haematol; 1986 Oct; 64(2):331-8. PubMed ID: 3778827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
    Kickler TS; Ness PM; Braine HG
    Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of four methods for platelet compatibility testing.
    McFarland JG; Aster RH
    Blood; 1987 May; 69(5):1425-30. PubMed ID: 3552075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of platelet alloantibodies by flow cytometry. Characterization and clinical significance.
    Rosenfeld CS; Bodensteiner DC
    Am J Clin Pathol; 1986 Feb; 85(2):207-12. PubMed ID: 3946304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.